カテゴリー： LP Information, 世界, 部品/材料

世界の製薬用シクロデキストリン市場予測 2023年-2029年

◆英語タイトル：Global Cyclodextrin in Pharma Market Growth 2023-2029
	◆商品コード：LP23JU6857 ◆発行会社（リサーチ会社）：LP Information ◆発行日：2023年5月 ◆ページ数：107 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など ◆産業分野：化学＆材料

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,660 ⇒換算￥549,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,490 ⇒換算￥823,500	見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）	USD7,320 ⇒換算￥1,098,000	見積依頼/購入/質問フォーム

★LP Informationに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の製薬用シクロデキストリン市場」は、過去の販売実績から2022年の世界の製薬用シクロデキストリンの総販売量を検討し、2023年から2029年の予測される製薬用シクロデキストリンの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の製薬用シクロデキストリンの市場規模を掲載し、XXX百万米ドル規模の世界の製薬用シクロデキストリン市場の詳細な分析を提供します。本インサイトレポートは、世界の製薬用シクロデキストリン業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の製薬用シクロデキストリン市場における各社の独自のポジションをより深く理解するために、製薬用シクロデキストリン製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の製薬用シクロデキストリン市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。製薬用シクロデキストリンの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。製薬用シクロデキストリンの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。製薬用シクロデキストリンのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

製薬用シクロデキストリンの世界主要メーカーとしては、Wacker、 Ensuiko Sugar Refining、 Nihon Shokuhin Kako、 Roquette、 Ashland、 Shandong Xinda、 Yunan Yongguang、 Qufu Tianli、 Zibo Qianhui、 Jiangsu Fengyuan、 Mengzhou Huaxing、 Mengzhou Hongjiなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の製薬用シクロデキストリン市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では製薬用シクロデキストリン市場をセグメンテーションし、種類別 (α-シクロデキストリン（医薬用）、β-シクロデキストリン（医薬用）、γ-シクロデキストリン（医薬用）、CD誘導体)、用途別 (錠剤・カプセル、注射剤)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：α-シクロデキストリン（医薬用）、β-シクロデキストリン（医薬用）、γ-シクロデキストリン（医薬用）、CD誘導体

・用途別区分：錠剤・カプセル、注射剤

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の製薬用シクロデキストリン市場の10年間の市場状況・展望は？
・世界および地域別に見た製薬用シクロデキストリン市場成長の要因は何か？
・製薬用シクロデキストリンの市場機会はエンドマーケットの規模によってどのように変化するのか？
・製薬用シクロデキストリンのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：製薬用シクロデキストリンの年間販売量2018-2029、地域別現状・将来分析
・製薬用シクロデキストリンの種類別セグメント：α-シクロデキストリン（医薬用）、β-シクロデキストリン（医薬用）、γ-シクロデキストリン（医薬用）、CD誘導体
・製薬用シクロデキストリンの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・製薬用シクロデキストリンの用途別セグメント：錠剤・カプセル、注射剤
・製薬用シクロデキストリンの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の製薬用シクロデキストリン市場
・企業別のグローバル製薬用シクロデキストリン市場データ：2018-2023年の年間販売量、市場シェア
・企業別の製薬用シクロデキストリンの年間売上：2018-2023年の売上、市場シェア
・企業別の製薬用シクロデキストリン販売価格
・主要企業の製薬用シクロデキストリン生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

製薬用シクロデキストリンの地域別レビュー
・地域別の製薬用シクロデキストリン市場規模2018-2023：年間販売量、売上
・主要国別の製薬用シクロデキストリン市場規模2018-2023：年間販売量、売上
・南北アメリカの製薬用シクロデキストリン販売の成長
・アジア太平洋の製薬用シクロデキストリン販売の成長
・ヨーロッパの製薬用シクロデキストリン販売の成長
・中東・アフリカの製薬用シクロデキストリン販売の成長

南北アメリカ市場
・南北アメリカの国別の製薬用シクロデキストリン販売量、売上（2018-2023）
・南北アメリカの製薬用シクロデキストリンの種類別販売量
・南北アメリカの製薬用シクロデキストリンの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の製薬用シクロデキストリン販売量、売上（2018-2023）
・アジア太平洋の製薬用シクロデキストリンの種類別販売量
・アジア太平洋の製薬用シクロデキストリンの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の製薬用シクロデキストリン販売量、売上（2018-2023）
・ヨーロッパの製薬用シクロデキストリンの種類別販売量
・ヨーロッパの製薬用シクロデキストリンの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の製薬用シクロデキストリン販売量、売上（2018-2023）
・中東・アフリカの製薬用シクロデキストリンの種類別販売量
・中東・アフリカの製薬用シクロデキストリンの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・製薬用シクロデキストリンの製造コスト構造分析
・製薬用シクロデキストリンの製造プロセス分析
・製薬用シクロデキストリンの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・製薬用シクロデキストリンの主要なグローバル販売業者
・製薬用シクロデキストリンの主要なグローバル顧客

地域別の製薬用シクロデキストリン市場予測レビュー
・地域別の製薬用シクロデキストリン市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・製薬用シクロデキストリンの種類別市場規模予測
・製薬用シクロデキストリンの用途別市場規模予測

主要企業分析
Wacker、 Ensuiko Sugar Refining、 Nihon Shokuhin Kako、 Roquette、 Ashland、 Shandong Xinda、 Yunan Yongguang、 Qufu Tianli、 Zibo Qianhui、 Jiangsu Fengyuan、 Mengzhou Huaxing、 Mengzhou Hongji
・企業情報
・製薬用シクロデキストリン製品
・製薬用シクロデキストリン販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

Cyclodextrins are a family of cyclic oligosaccharides, consisting of a macrocyclic ring of glucose subunits joined by α-1,4 glycosidic bonds. Cyclodextrins are produced from starch by enzymatic conversion. They are used in food, pharmaceutical, drug delivery, and chemical industries, as well as agriculture and environmental engineering.
LPI (LP Information)’ newest research report, the “Cyclodextrin in Pharma Industry Forecast” looks at past sales and reviews total world Cyclodextrin in Pharma sales in 2022, providing a comprehensive analysis by region and market sector of projected Cyclodextrin in Pharma sales for 2023 through 2029. With Cyclodextrin in Pharma sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cyclodextrin in Pharma industry.
This Insight Report provides a comprehensive analysis of the global Cyclodextrin in Pharma landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cyclodextrin in Pharma portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cyclodextrin in Pharma market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cyclodextrin in Pharma and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cyclodextrin in Pharma.
The global Cyclodextrin in Pharma market size is projected to grow from US$ 35 million in 2022 to US$ 56 million in 2029; it is expected to grow at a CAGR of 56 from 2023 to 2029.
Global key manufacturers of cyclodextrin in pharma include Wacker, Ensuiko Sugar Refining, Ashland, etc. Global top 3 manufacturers hold a share above 60%. Europe and North America are the major producing regions in the world, followed by China and Japan. In terms of application, the product is most widely used in tablets and capsules, followed by injectables.
This report presents a comprehensive overview, market shares, and growth opportunities of Cyclodextrin in Pharma market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Alpha-Cyclodextrin in Pharma
Beta-Cyclodextrin in Pharma
Gamma-Cyclodextrin in Pharma
CD Derivatives
Segmentation by application
Tablets and Capsules
Injectables
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Wacker
Ensuiko Sugar Refining
Nihon Shokuhin Kako
Roquette
Ashland
Shandong Xinda
Yunan Yongguang
Qufu Tianli
Zibo Qianhui
Jiangsu Fengyuan
Mengzhou Huaxing
Mengzhou Hongji
Key Questions Addressed in this Report
What is the 10-year outlook for the global Cyclodextrin in Pharma market?
What factors are driving Cyclodextrin in Pharma market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cyclodextrin in Pharma market opportunities vary by end market size?
How does Cyclodextrin in Pharma break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cyclodextrin in Pharma Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Cyclodextrin in Pharma by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Cyclodextrin in Pharma by Country/Region, 2018, 2022 & 2029
2.2 Cyclodextrin in Pharma Segment by Type
2.2.1 Alpha-Cyclodextrin in Pharma
2.2.2 Beta-Cyclodextrin in Pharma
2.2.3 Gamma-Cyclodextrin in Pharma
2.2.4 CD Derivatives
2.3 Cyclodextrin in Pharma Sales by Type
2.3.1 Global Cyclodextrin in Pharma Sales Market Share by Type (2018-2023)
2.3.2 Global Cyclodextrin in Pharma Revenue and Market Share by Type (2018-2023)
2.3.3 Global Cyclodextrin in Pharma Sale Price by Type (2018-2023)
2.4 Cyclodextrin in Pharma Segment by Application
2.4.1 Tablets and Capsules
2.4.2 Injectables
2.5 Cyclodextrin in Pharma Sales by Application
2.5.1 Global Cyclodextrin in Pharma Sale Market Share by Application (2018-2023)
2.5.2 Global Cyclodextrin in Pharma Revenue and Market Share by Application (2018-2023)
2.5.3 Global Cyclodextrin in Pharma Sale Price by Application (2018-2023)
3 Global Cyclodextrin in Pharma by Company
3.1 Global Cyclodextrin in Pharma Breakdown Data by Company
3.1.1 Global Cyclodextrin in Pharma Annual Sales by Company (2018-2023)
3.1.2 Global Cyclodextrin in Pharma Sales Market Share by Company (2018-2023)
3.2 Global Cyclodextrin in Pharma Annual Revenue by Company (2018-2023)
3.2.1 Global Cyclodextrin in Pharma Revenue by Company (2018-2023)
3.2.2 Global Cyclodextrin in Pharma Revenue Market Share by Company (2018-2023)
3.3 Global Cyclodextrin in Pharma Sale Price by Company
3.4 Key Manufacturers Cyclodextrin in Pharma Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cyclodextrin in Pharma Product Location Distribution
3.4.2 Players Cyclodextrin in Pharma Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Cyclodextrin in Pharma by Geographic Region
4.1 World Historic Cyclodextrin in Pharma Market Size by Geographic Region (2018-2023)
4.1.1 Global Cyclodextrin in Pharma Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Cyclodextrin in Pharma Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Cyclodextrin in Pharma Market Size by Country/Region (2018-2023)
4.2.1 Global Cyclodextrin in Pharma Annual Sales by Country/Region (2018-2023)
4.2.2 Global Cyclodextrin in Pharma Annual Revenue by Country/Region (2018-2023)
4.3 Americas Cyclodextrin in Pharma Sales Growth
4.4 APAC Cyclodextrin in Pharma Sales Growth
4.5 Europe Cyclodextrin in Pharma Sales Growth
4.6 Middle East & Africa Cyclodextrin in Pharma Sales Growth
5 Americas
5.1 Americas Cyclodextrin in Pharma Sales by Country
5.1.1 Americas Cyclodextrin in Pharma Sales by Country (2018-2023)
5.1.2 Americas Cyclodextrin in Pharma Revenue by Country (2018-2023)
5.2 Americas Cyclodextrin in Pharma Sales by Type
5.3 Americas Cyclodextrin in Pharma Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cyclodextrin in Pharma Sales by Region
6.1.1 APAC Cyclodextrin in Pharma Sales by Region (2018-2023)
6.1.2 APAC Cyclodextrin in Pharma Revenue by Region (2018-2023)
6.2 APAC Cyclodextrin in Pharma Sales by Type
6.3 APAC Cyclodextrin in Pharma Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Cyclodextrin in Pharma by Country
7.1.1 Europe Cyclodextrin in Pharma Sales by Country (2018-2023)
7.1.2 Europe Cyclodextrin in Pharma Revenue by Country (2018-2023)
7.2 Europe Cyclodextrin in Pharma Sales by Type
7.3 Europe Cyclodextrin in Pharma Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cyclodextrin in Pharma by Country
8.1.1 Middle East & Africa Cyclodextrin in Pharma Sales by Country (2018-2023)
8.1.2 Middle East & Africa Cyclodextrin in Pharma Revenue by Country (2018-2023)
8.2 Middle East & Africa Cyclodextrin in Pharma Sales by Type
8.3 Middle East & Africa Cyclodextrin in Pharma Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cyclodextrin in Pharma
10.3 Manufacturing Process Analysis of Cyclodextrin in Pharma
10.4 Industry Chain Structure of Cyclodextrin in Pharma
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cyclodextrin in Pharma Distributors
11.3 Cyclodextrin in Pharma Customer
12 World Forecast Review for Cyclodextrin in Pharma by Geographic Region
12.1 Global Cyclodextrin in Pharma Market Size Forecast by Region
12.1.1 Global Cyclodextrin in Pharma Forecast by Region (2024-2029)
12.1.2 Global Cyclodextrin in Pharma Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Cyclodextrin in Pharma Forecast by Type
12.7 Global Cyclodextrin in Pharma Forecast by Application
13 Key Players Analysis
13.1 Wacker
13.1.1 Wacker Company Information
13.1.2 Wacker Cyclodextrin in Pharma Product Portfolios and Specifications
13.1.3 Wacker Cyclodextrin in Pharma Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Wacker Main Business Overview
13.1.5 Wacker Latest Developments
13.2 Ensuiko Sugar Refining
13.2.1 Ensuiko Sugar Refining Company Information
13.2.2 Ensuiko Sugar Refining Cyclodextrin in Pharma Product Portfolios and Specifications
13.2.3 Ensuiko Sugar Refining Cyclodextrin in Pharma Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Ensuiko Sugar Refining Main Business Overview
13.2.5 Ensuiko Sugar Refining Latest Developments
13.3 Nihon Shokuhin Kako
13.3.1 Nihon Shokuhin Kako Company Information
13.3.2 Nihon Shokuhin Kako Cyclodextrin in Pharma Product Portfolios and Specifications
13.3.3 Nihon Shokuhin Kako Cyclodextrin in Pharma Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Nihon Shokuhin Kako Main Business Overview
13.3.5 Nihon Shokuhin Kako Latest Developments
13.4 Roquette
13.4.1 Roquette Company Information
13.4.2 Roquette Cyclodextrin in Pharma Product Portfolios and Specifications
13.4.3 Roquette Cyclodextrin in Pharma Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Roquette Main Business Overview
13.4.5 Roquette Latest Developments
13.5 Ashland
13.5.1 Ashland Company Information
13.5.2 Ashland Cyclodextrin in Pharma Product Portfolios and Specifications
13.5.3 Ashland Cyclodextrin in Pharma Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Ashland Main Business Overview
13.5.5 Ashland Latest Developments
13.6 Shandong Xinda
13.6.1 Shandong Xinda Company Information
13.6.2 Shandong Xinda Cyclodextrin in Pharma Product Portfolios and Specifications
13.6.3 Shandong Xinda Cyclodextrin in Pharma Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Shandong Xinda Main Business Overview
13.6.5 Shandong Xinda Latest Developments
13.7 Yunan Yongguang
13.7.1 Yunan Yongguang Company Information
13.7.2 Yunan Yongguang Cyclodextrin in Pharma Product Portfolios and Specifications
13.7.3 Yunan Yongguang Cyclodextrin in Pharma Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Yunan Yongguang Main Business Overview
13.7.5 Yunan Yongguang Latest Developments
13.8 Qufu Tianli
13.8.1 Qufu Tianli Company Information
13.8.2 Qufu Tianli Cyclodextrin in Pharma Product Portfolios and Specifications
13.8.3 Qufu Tianli Cyclodextrin in Pharma Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Qufu Tianli Main Business Overview
13.8.5 Qufu Tianli Latest Developments
13.9 Zibo Qianhui
13.9.1 Zibo Qianhui Company Information
13.9.2 Zibo Qianhui Cyclodextrin in Pharma Product Portfolios and Specifications
13.9.3 Zibo Qianhui Cyclodextrin in Pharma Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Zibo Qianhui Main Business Overview
13.9.5 Zibo Qianhui Latest Developments
13.10 Jiangsu Fengyuan
13.10.1 Jiangsu Fengyuan Company Information
13.10.2 Jiangsu Fengyuan Cyclodextrin in Pharma Product Portfolios and Specifications
13.10.3 Jiangsu Fengyuan Cyclodextrin in Pharma Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Jiangsu Fengyuan Main Business Overview
13.10.5 Jiangsu Fengyuan Latest Developments
13.11 Mengzhou Huaxing
13.11.1 Mengzhou Huaxing Company Information
13.11.2 Mengzhou Huaxing Cyclodextrin in Pharma Product Portfolios and Specifications
13.11.3 Mengzhou Huaxing Cyclodextrin in Pharma Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Mengzhou Huaxing Main Business Overview
13.11.5 Mengzhou Huaxing Latest Developments
13.12 Mengzhou Hongji
13.12.1 Mengzhou Hongji Company Information
13.12.2 Mengzhou Hongji Cyclodextrin in Pharma Product Portfolios and Specifications
13.12.3 Mengzhou Hongji Cyclodextrin in Pharma Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Mengzhou Hongji Main Business Overview
13.12.5 Mengzhou Hongji Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Cyclodextrin in Pharma Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Cyclodextrin in Pharma Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Alpha-Cyclodextrin in Pharma
Table 4. Major Players of Beta-Cyclodextrin in Pharma
Table 5. Major Players of Gamma-Cyclodextrin in Pharma
Table 6. Major Players of CD Derivatives
Table 7. Global Cyclodextrin in Pharma Sales by Type (2018-2023) & (MT)
Table 8. Global Cyclodextrin in Pharma Sales Market Share by Type (2018-2023)
Table 9. Global Cyclodextrin in Pharma Revenue by Type (2018-2023) & ($ million)
Table 10. Global Cyclodextrin in Pharma Revenue Market Share by Type (2018-2023)
Table 11. Global Cyclodextrin in Pharma Sale Price by Type (2018-2023) & (USD/MT)
Table 12. Global Cyclodextrin in Pharma Sales by Application (2018-2023) & (MT)
Table 13. Global Cyclodextrin in Pharma Sales Market Share by Application (2018-2023)
Table 14. Global Cyclodextrin in Pharma Revenue by Application (2018-2023)
Table 15. Global Cyclodextrin in Pharma Revenue Market Share by Application (2018-2023)
Table 16. Global Cyclodextrin in Pharma Sale Price by Application (2018-2023) & (USD/MT)
Table 17. Global Cyclodextrin in Pharma Sales by Company (2018-2023) & (MT)
Table 18. Global Cyclodextrin in Pharma Sales Market Share by Company (2018-2023)
Table 19. Global Cyclodextrin in Pharma Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Cyclodextrin in Pharma Revenue Market Share by Company (2018-2023)
Table 21. Global Cyclodextrin in Pharma Sale Price by Company (2018-2023) & (USD/MT)
Table 22. Key Manufacturers Cyclodextrin in Pharma Producing Area Distribution and Sales Area
Table 23. Players Cyclodextrin in Pharma Products Offered
Table 24. Cyclodextrin in Pharma Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Cyclodextrin in Pharma Sales by Geographic Region (2018-2023) & (MT)
Table 28. Global Cyclodextrin in Pharma Sales Market Share Geographic Region (2018-2023)
Table 29. Global Cyclodextrin in Pharma Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Cyclodextrin in Pharma Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Cyclodextrin in Pharma Sales by Country/Region (2018-2023) & (MT)
Table 32. Global Cyclodextrin in Pharma Sales Market Share by Country/Region (2018-2023)
Table 33. Global Cyclodextrin in Pharma Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Cyclodextrin in Pharma Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Cyclodextrin in Pharma Sales by Country (2018-2023) & (MT)
Table 36. Americas Cyclodextrin in Pharma Sales Market Share by Country (2018-2023)
Table 37. Americas Cyclodextrin in Pharma Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Cyclodextrin in Pharma Revenue Market Share by Country (2018-2023)
Table 39. Americas Cyclodextrin in Pharma Sales by Type (2018-2023) & (MT)
Table 40. Americas Cyclodextrin in Pharma Sales by Application (2018-2023) & (MT)
Table 41. APAC Cyclodextrin in Pharma Sales by Region (2018-2023) & (MT)
Table 42. APAC Cyclodextrin in Pharma Sales Market Share by Region (2018-2023)
Table 43. APAC Cyclodextrin in Pharma Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Cyclodextrin in Pharma Revenue Market Share by Region (2018-2023)
Table 45. APAC Cyclodextrin in Pharma Sales by Type (2018-2023) & (MT)
Table 46. APAC Cyclodextrin in Pharma Sales by Application (2018-2023) & (MT)
Table 47. Europe Cyclodextrin in Pharma Sales by Country (2018-2023) & (MT)
Table 48. Europe Cyclodextrin in Pharma Sales Market Share by Country (2018-2023)
Table 49. Europe Cyclodextrin in Pharma Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Cyclodextrin in Pharma Revenue Market Share by Country (2018-2023)
Table 51. Europe Cyclodextrin in Pharma Sales by Type (2018-2023) & (MT)
Table 52. Europe Cyclodextrin in Pharma Sales by Application (2018-2023) & (MT)
Table 53. Middle East & Africa Cyclodextrin in Pharma Sales by Country (2018-2023) & (MT)
Table 54. Middle East & Africa Cyclodextrin in Pharma Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Cyclodextrin in Pharma Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Cyclodextrin in Pharma Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Cyclodextrin in Pharma Sales by Type (2018-2023) & (MT)
Table 58. Middle East & Africa Cyclodextrin in Pharma Sales by Application (2018-2023) & (MT)
Table 59. Key Market Drivers & Growth Opportunities of Cyclodextrin in Pharma
Table 60. Key Market Challenges & Risks of Cyclodextrin in Pharma
Table 61. Key Industry Trends of Cyclodextrin in Pharma
Table 62. Cyclodextrin in Pharma Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Cyclodextrin in Pharma Distributors List
Table 65. Cyclodextrin in Pharma Customer List
Table 66. Global Cyclodextrin in Pharma Sales Forecast by Region (2024-2029) & (MT)
Table 67. Global Cyclodextrin in Pharma Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Cyclodextrin in Pharma Sales Forecast by Country (2024-2029) & (MT)
Table 69. Americas Cyclodextrin in Pharma Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Cyclodextrin in Pharma Sales Forecast by Region (2024-2029) & (MT)
Table 71. APAC Cyclodextrin in Pharma Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Cyclodextrin in Pharma Sales Forecast by Country (2024-2029) & (MT)
Table 73. Europe Cyclodextrin in Pharma Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Cyclodextrin in Pharma Sales Forecast by Country (2024-2029) & (MT)
Table 75. Middle East & Africa Cyclodextrin in Pharma Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Cyclodextrin in Pharma Sales Forecast by Type (2024-2029) & (MT)
Table 77. Global Cyclodextrin in Pharma Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Cyclodextrin in Pharma Sales Forecast by Application (2024-2029) & (MT)
Table 79. Global Cyclodextrin in Pharma Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Wacker Basic Information, Cyclodextrin in Pharma Manufacturing Base, Sales Area and Its Competitors
Table 81. Wacker Cyclodextrin in Pharma Product Portfolios and Specifications
Table 82. Wacker Cyclodextrin in Pharma Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 83. Wacker Main Business
Table 84. Wacker Latest Developments
Table 85. Ensuiko Sugar Refining Basic Information, Cyclodextrin in Pharma Manufacturing Base, Sales Area and Its Competitors
Table 86. Ensuiko Sugar Refining Cyclodextrin in Pharma Product Portfolios and Specifications
Table 87. Ensuiko Sugar Refining Cyclodextrin in Pharma Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 88. Ensuiko Sugar Refining Main Business
Table 89. Ensuiko Sugar Refining Latest Developments
Table 90. Nihon Shokuhin Kako Basic Information, Cyclodextrin in Pharma Manufacturing Base, Sales Area and Its Competitors
Table 91. Nihon Shokuhin Kako Cyclodextrin in Pharma Product Portfolios and Specifications
Table 92. Nihon Shokuhin Kako Cyclodextrin in Pharma Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 93. Nihon Shokuhin Kako Main Business
Table 94. Nihon Shokuhin Kako Latest Developments
Table 95. Roquette Basic Information, Cyclodextrin in Pharma Manufacturing Base, Sales Area and Its Competitors
Table 96. Roquette Cyclodextrin in Pharma Product Portfolios and Specifications
Table 97. Roquette Cyclodextrin in Pharma Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 98. Roquette Main Business
Table 99. Roquette Latest Developments
Table 100. Ashland Basic Information, Cyclodextrin in Pharma Manufacturing Base, Sales Area and Its Competitors
Table 101. Ashland Cyclodextrin in Pharma Product Portfolios and Specifications
Table 102. Ashland Cyclodextrin in Pharma Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 103. Ashland Main Business
Table 104. Ashland Latest Developments
Table 105. Shandong Xinda Basic Information, Cyclodextrin in Pharma Manufacturing Base, Sales Area and Its Competitors
Table 106. Shandong Xinda Cyclodextrin in Pharma Product Portfolios and Specifications
Table 107. Shandong Xinda Cyclodextrin in Pharma Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 108. Shandong Xinda Main Business
Table 109. Shandong Xinda Latest Developments
Table 110. Yunan Yongguang Basic Information, Cyclodextrin in Pharma Manufacturing Base, Sales Area and Its Competitors
Table 111. Yunan Yongguang Cyclodextrin in Pharma Product Portfolios and Specifications
Table 112. Yunan Yongguang Cyclodextrin in Pharma Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 113. Yunan Yongguang Main Business
Table 114. Yunan Yongguang Latest Developments
Table 115. Qufu Tianli Basic Information, Cyclodextrin in Pharma Manufacturing Base, Sales Area and Its Competitors
Table 116. Qufu Tianli Cyclodextrin in Pharma Product Portfolios and Specifications
Table 117. Qufu Tianli Cyclodextrin in Pharma Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 118. Qufu Tianli Main Business
Table 119. Qufu Tianli Latest Developments
Table 120. Zibo Qianhui Basic Information, Cyclodextrin in Pharma Manufacturing Base, Sales Area and Its Competitors
Table 121. Zibo Qianhui Cyclodextrin in Pharma Product Portfolios and Specifications
Table 122. Zibo Qianhui Cyclodextrin in Pharma Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 123. Zibo Qianhui Main Business
Table 124. Zibo Qianhui Latest Developments
Table 125. Jiangsu Fengyuan Basic Information, Cyclodextrin in Pharma Manufacturing Base, Sales Area and Its Competitors
Table 126. Jiangsu Fengyuan Cyclodextrin in Pharma Product Portfolios and Specifications
Table 127. Jiangsu Fengyuan Cyclodextrin in Pharma Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 128. Jiangsu Fengyuan Main Business
Table 129. Jiangsu Fengyuan Latest Developments
Table 130. Mengzhou Huaxing Basic Information, Cyclodextrin in Pharma Manufacturing Base, Sales Area and Its Competitors
Table 131. Mengzhou Huaxing Cyclodextrin in Pharma Product Portfolios and Specifications
Table 132. Mengzhou Huaxing Cyclodextrin in Pharma Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 133. Mengzhou Huaxing Main Business
Table 134. Mengzhou Huaxing Latest Developments
Table 135. Mengzhou Hongji Basic Information, Cyclodextrin in Pharma Manufacturing Base, Sales Area and Its Competitors
Table 136. Mengzhou Hongji Cyclodextrin in Pharma Product Portfolios and Specifications
Table 137. Mengzhou Hongji Cyclodextrin in Pharma Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 138. Mengzhou Hongji Main Business
Table 139. Mengzhou Hongji Latest Developments
List of Figures
Figure 1. Picture of Cyclodextrin in Pharma
Figure 2. Cyclodextrin in Pharma Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cyclodextrin in Pharma Sales Growth Rate 2018-2029 (MT)
Figure 7. Global Cyclodextrin in Pharma Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Cyclodextrin in Pharma Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Alpha-Cyclodextrin in Pharma
Figure 10. Product Picture of Beta-Cyclodextrin in Pharma
Figure 11. Product Picture of Gamma-Cyclodextrin in Pharma
Figure 12. Product Picture of CD Derivatives
Figure 13. Global Cyclodextrin in Pharma Sales Market Share by Type in 2022
Figure 14. Global Cyclodextrin in Pharma Revenue Market Share by Type (2018-2023)
Figure 15. Cyclodextrin in Pharma Consumed in Tablets and Capsules
Figure 16. Global Cyclodextrin in Pharma Market: Tablets and Capsules (2018-2023) & (MT)
Figure 17. Cyclodextrin in Pharma Consumed in Injectables
Figure 18. Global Cyclodextrin in Pharma Market: Injectables (2018-2023) & (MT)
Figure 19. Global Cyclodextrin in Pharma Sales Market Share by Application (2022)
Figure 20. Global Cyclodextrin in Pharma Revenue Market Share by Application in 2022
Figure 21. Cyclodextrin in Pharma Sales Market by Company in 2022 (MT)
Figure 22. Global Cyclodextrin in Pharma Sales Market Share by Company in 2022
Figure 23. Cyclodextrin in Pharma Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Cyclodextrin in Pharma Revenue Market Share by Company in 2022
Figure 25. Global Cyclodextrin in Pharma Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Cyclodextrin in Pharma Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Cyclodextrin in Pharma Sales 2018-2023 (MT)
Figure 28. Americas Cyclodextrin in Pharma Revenue 2018-2023 ($ Millions)
Figure 29. APAC Cyclodextrin in Pharma Sales 2018-2023 (MT)
Figure 30. APAC Cyclodextrin in Pharma Revenue 2018-2023 ($ Millions)
Figure 31. Europe Cyclodextrin in Pharma Sales 2018-2023 (MT)
Figure 32. Europe Cyclodextrin in Pharma Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Cyclodextrin in Pharma Sales 2018-2023 (MT)
Figure 34. Middle East & Africa Cyclodextrin in Pharma Revenue 2018-2023 ($ Millions)
Figure 35. Americas Cyclodextrin in Pharma Sales Market Share by Country in 2022
Figure 36. Americas Cyclodextrin in Pharma Revenue Market Share by Country in 2022
Figure 37. Americas Cyclodextrin in Pharma Sales Market Share by Type (2018-2023)
Figure 38. Americas Cyclodextrin in Pharma Sales Market Share by Application (2018-2023)
Figure 39. United States Cyclodextrin in Pharma Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Cyclodextrin in Pharma Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Cyclodextrin in Pharma Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Cyclodextrin in Pharma Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Cyclodextrin in Pharma Sales Market Share by Region in 2022
Figure 44. APAC Cyclodextrin in Pharma Revenue Market Share by Regions in 2022
Figure 45. APAC Cyclodextrin in Pharma Sales Market Share by Type (2018-2023)
Figure 46. APAC Cyclodextrin in Pharma Sales Market Share by Application (2018-2023)
Figure 47. China Cyclodextrin in Pharma Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Cyclodextrin in Pharma Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Cyclodextrin in Pharma Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Cyclodextrin in Pharma Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Cyclodextrin in Pharma Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Cyclodextrin in Pharma Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Cyclodextrin in Pharma Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Cyclodextrin in Pharma Sales Market Share by Country in 2022
Figure 55. Europe Cyclodextrin in Pharma Revenue Market Share by Country in 2022
Figure 56. Europe Cyclodextrin in Pharma Sales Market Share by Type (2018-2023)
Figure 57. Europe Cyclodextrin in Pharma Sales Market Share by Application (2018-2023)
Figure 58. Germany Cyclodextrin in Pharma Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Cyclodextrin in Pharma Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Cyclodextrin in Pharma Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Cyclodextrin in Pharma Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Cyclodextrin in Pharma Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Cyclodextrin in Pharma Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Cyclodextrin in Pharma Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Cyclodextrin in Pharma Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Cyclodextrin in Pharma Sales Market Share by Application (2018-2023)
Figure 67. Egypt Cyclodextrin in Pharma Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Cyclodextrin in Pharma Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Cyclodextrin in Pharma Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Cyclodextrin in Pharma Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Cyclodextrin in Pharma Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Cyclodextrin in Pharma in 2022
Figure 73. Manufacturing Process Analysis of Cyclodextrin in Pharma
Figure 74. Industry Chain Structure of Cyclodextrin in Pharma
Figure 75. Channels of Distribution
Figure 76. Global Cyclodextrin in Pharma Sales Market Forecast by Region (2024-2029)
Figure 77. Global Cyclodextrin in Pharma Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Cyclodextrin in Pharma Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Cyclodextrin in Pharma Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Cyclodextrin in Pharma Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Cyclodextrin in Pharma Revenue Market Share Forecast by Application (2024-2029)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の製薬用シクロデキストリン市場予測 2023年-2029年(Global Cyclodextrin in Pharma Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の製薬用シクロデキストリン市場予測 2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp